{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:44:02Z","timestamp":1740149042251,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100011338","name":"AstraZeneca Schweiz","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100011338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s12265-020-10094-5","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T20:20:58Z","timestamp":1610137258000},"page":"790-798","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Number of Antithrombotic Drugs Used Early and In-hospital Outcomes in Acute Coronary Syndromes"],"prefix":"10.1007","volume":"14","author":[{"given":"Roberto","family":"Mart\u00edn-Asenjo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Gregson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6783-8463","authenticated-orcid":false,"given":"Xavier","family":"Rossello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frans","family":"Van de Werf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Danchin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Pocock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9ctor","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,8]]},"reference":[{"issue":"5","key":"10094_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1177\/2048872619845283","volume":"8","author":"X Rossello","year":"2019","unstructured":"Rossello, X., Lobo-Gonzalez, M., & Ibanez, B. (2019). Editor\u2019s choice- pathophysiology and therapy of myocardial ischaemia\/reperfusion syndrome. European Heart Journal: Acute Cardiovascular Care, 8(5), 443\u2013456. https:\/\/doi.org\/10.1177\/2048872619845283.","journal-title":"European Heart Journal: Acute Cardiovascular Care"},{"issue":"11","key":"10094_CR2","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.jacc.2015.07.018","volume":"66","author":"X Rossello","year":"2015","unstructured":"Rossello, X., Pocock, S. J., & Julian, D. G. (2015). Long-term use of cardiovascular drugs. Journal of the American College of Cardiology, 66(11), 1273\u20131285. https:\/\/doi.org\/10.1016\/j.jacc.2015.07.018.","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"10094_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2017","unstructured":"Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., et al. (2017). 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal, 39(2), 119\u2013177. https:\/\/doi.org\/10.1093\/eurheartj\/ehx393.","journal-title":"European Heart Journal"},{"issue":"3","key":"10094_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M Roffi","year":"2016","unstructured":"Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., et al. (2016). 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal, 37(3), 267\u2013315. https:\/\/doi.org\/10.1093\/eurheartj\/ehv320.","journal-title":"European Heart Journal"},{"issue":"24","key":"10094_CR5","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","volume":"64","author":"EA Amsterdam","year":"2014","unstructured":"Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., et al. (2014). 2014 AHA\/ACC Guideline for the management of patients with non\u2013ST-elevation acute coronary syndromes. Journal of the American College of Cardiology, 64(24), e139\u2013e228. https:\/\/doi.org\/10.1016\/j.jacc.2014.09.017.","journal-title":"Journal of the American College of Cardiology"},{"key":"10094_CR6","doi-asserted-by":"publisher","unstructured":"O\u2019Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., \u2026 Yancy, C. W. (2013). 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology, 61(4), e78-140. https:\/\/doi.org\/10.1016\/j.jacc.2012.11.019","DOI":"10.1016\/j.jacc.2012.11.019"},{"key":"10094_CR7","doi-asserted-by":"publisher","unstructured":"Rollini, F., Franchi, F., & Angiolillo, D. J. (2016, January 1). Switching P2Y12-receptor inhibitors in patients with coronary artery disease. Nature Reviews Cardiology. Nature Publishing Group. https:\/\/doi.org\/10.1038\/nrcardio.2015.113.","DOI":"10.1038\/nrcardio.2015.113"},{"issue":"1","key":"10094_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ahj.2012.10.018","volume":"165","author":"H Bueno","year":"2013","unstructured":"Bueno, H., Danchin, N., Tafalla, M., Bernaud, C., Annemans, L., & Van de Werf, F. (2013). EPICOR (long-tErm follow-up of antithrombotic management Patterns In acute CORonary syndrome patients) study: rationale, design, and baseline characteristics. American heart journal, 165(1), 8\u201314. https:\/\/doi.org\/10.1016\/j.ahj.2012.10.018.","journal-title":"American heart journal"},{"issue":"2","key":"10094_CR9","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1136\/heartjnl-2016-309509","volume":"103","author":"H Bueno","year":"2017","unstructured":"Bueno, H., Pocock, S., Danchin, N., Annemans, L., Gregson, J., Medina, J., & Van de Werf, F. (2017). International patterns of dual antiplatelet therapy duration after acute coronary syndromes. Heart, 103(2), 132\u2013138. https:\/\/doi.org\/10.1136\/heartjnl-2016-309509.","journal-title":"Heart"},{"key":"10094_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijcard.2017.07.039","volume":"245","author":"X Rossell\u00f3","year":"2017","unstructured":"Rossell\u00f3, X., Huo, Y., Pocock, S., Van de Werf, F., Chin, C. T., Danchin, N., et al. (2017). Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortality. International Journal of Cardiology, 245, 27\u201334. https:\/\/doi.org\/10.1016\/j.ijcard.2017.07.039.","journal-title":"International Journal of Cardiology"},{"issue":"9","key":"10094_CR11","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s00392-018-1254-y","volume":"107","author":"H Bueno","year":"2018","unstructured":"Bueno, H., Rossello, X., Pocock, S., Van de Werf, F., Chin, C. T., Danchin, N., et al. (2018). Regional variations in hospital management and post-discharge mortality in patients with non-ST-segment elevation acute coronary syndrome. Clinical Research in Cardiology, 107(9), 836\u2013844. https:\/\/doi.org\/10.1007\/s00392-018-1254-y.","journal-title":"Clinical Research in Cardiology"},{"issue":"4","key":"10094_CR12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","volume":"30","author":"IR White","year":"2011","unstructured":"White, I. R., Royston, P., & Wood, A. M. (2011). Multiple imputation using chained equations: Issues and guidance for practice. Statistics in medicine, 30(4), 377\u2013399. https:\/\/doi.org\/10.1002\/sim.4067.","journal-title":"Statistics in medicine"},{"issue":"8","key":"10094_CR13","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1177\/2048872617719638","volume":"8","author":"SJ Pocock","year":"2019","unstructured":"Pocock, S. J., Huo, Y., Van de Werf, F., Newsome, S., Chin, C. T., Vega, A. M., et al. (2019). Predicting two-year mortality from discharge after acute coronary syndrome: an internationally-based risk score. European Heart Journal: Acute Cardiovascular Care, 8(8), 727\u2013737. https:\/\/doi.org\/10.1177\/2048872617719638.","journal-title":"European Heart Journal: Acute Cardiovascular Care"},{"issue":"11","key":"10094_CR14","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.jacc.2019.06.068","volume":"74","author":"H Bueno","year":"2019","unstructured":"Bueno, H., Rossello, X., Pocock, S. J., Van de Werf, F., Chin, C. T., Danchin, N., et al. (2019). In-hospital coronary revascularization rates and post-discharge mortality risk in non\u2013ST-segment elevation acute coronary syndrome. Journal of the American College of Cardiology, 74(11), 1454\u20131461. https:\/\/doi.org\/10.1016\/j.jacc.2019.06.068.","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10094_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/2048872614565912","volume":"5","author":"H Bueno","year":"2016","unstructured":"Bueno, H., Sinnaeve, P., Annemans, L., Danchin, N., Licour, M., Medina, J., et al. (2016). Opportunities for improvement in anti-thrombotic therapy and other strategies for the management of acute coronary syndromes: insights from EPICOR, an international study of current practice patterns. European heart journal. Acute cardiovascular care, 5(1), 3\u201312. https:\/\/doi.org\/10.1177\/2048872614565912.","journal-title":"European heart journal. Acute cardiovascular care"},{"key":"10094_CR16","doi-asserted-by":"publisher","unstructured":"Raposeiras-Roub\u00edn, S., Abu-Assi, E., Mu\u00f1oz-Pousa, I., Rossello, X., Cesp\u00f3n-Fern\u00e1ndez, M., Melendo Viu, M., et al. (2020). Usefulness of bleeding after acute coronary syndromes for unmasking silent cancer. American Journal of Cardiology,\u00a0125(12), 1801\u20131808. https:\/\/doi.org\/10.1016\/j.amjcard.2020.03.023.","DOI":"10.1016\/j.amjcard.2020.03.023"},{"issue":"8","key":"10094_CR17","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.106.612812","volume":"114","author":"JW Eikelboom","year":"2006","unstructured":"Eikelboom, J. W., Mehta, S. R., Anand, S. S., Xie, C., Fox, K. A. A., & Yusuf, S. (2006). Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation, 114(8), 774\u2013782. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.612812.","journal-title":"Circulation"},{"issue":"1","key":"10094_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.recesp.2011.08.005","volume":"65","author":"G Erdem","year":"2012","unstructured":"Erdem, G., & Flather, M. (2012). Assessing bleeding risk in acute coronary syndromes. Revista Espanola de Cardiologia, 65(1), 4\u20136. https:\/\/doi.org\/10.1016\/j.recesp.2011.08.005.","journal-title":"Revista Espanola de Cardiologia"},{"issue":"15","key":"10094_CR19","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1093\/eurheartj\/ehr204","volume":"32","author":"PG Steg","year":"2011","unstructured":"Steg, P. G., Huber, K., Andreotti, F., Arnesen, H., Atar, D., Badimon, L., et al. (2011). Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. European heart journal, 32(15), 1854\u20131864. https:\/\/doi.org\/10.1093\/eurheartj\/ehr204.","journal-title":"European heart journal"},{"issue":"3","key":"10094_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"M Valgimigli","year":"2018","unstructured":"Valgimigli, M., Bueno, H., Byrne, R. A., Collet, J.-P., Costa, F., Jeppsson, A., et al. (2018). 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). European heart journal, 39(3), 213\u2013260. https:\/\/doi.org\/10.1093\/eurheartj\/ehx419.","journal-title":"European heart journal"},{"issue":"20","key":"10094_CR21","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1161\/CIRCULATIONAHA.117.031164","volume":"136","author":"DJ Angiolillo","year":"2017","unstructured":"Angiolillo, D. J., Rollini, F., Storey, R. F., Bhatt, D. L., James, S., Schneider, D. J., et al. (2017). International expert consensus on switching platelet P2Y12 receptor-inhibiting therapies. Circulation, 136(20), 1955\u20131975. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.031164.","journal-title":"Circulation"},{"key":"10094_CR22","doi-asserted-by":"publisher","unstructured":"Rossello, X., Medina, J., Pocock, S., Van de Werf, F., Chin, C. T., Danchin, N., et al. (2020). Assessment of quality indicators for acute myocardial infarction management in 28 countries and use of composite quality indicators for benchmarking. European Heart Journal: Acute Cardiovascular Care,\u00a09(8), 911\u2013922. https:\/\/doi.org\/10.1177\/2048872620911853.","DOI":"10.1177\/2048872620911853"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-020-10094-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-020-10094-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-020-10094-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T15:18:18Z","timestamp":1630077498000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-020-10094-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,8]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10094"],"URL":"https:\/\/doi.org\/10.1007\/s12265-020-10094-5","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"type":"print","value":"1937-5387"},{"type":"electronic","value":"1937-5395"}],"subject":[],"published":{"date-parts":[[2021,1,8]]},"assertion":[{"value":"20 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No animal studies were carried out by the authors for this article. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Standards"}},{"value":"RMA has received consulting fees from AstraZeneca and Bayer, and speaking fees or support for attending scientific meetings from Daichii-Sankyo, Bayer, and Cardiome. JG has received grants from AstraZeneca during the conduct of the study and outside of the submitted work. XR has nothing to disclose. FVdW has received consulting fees and research grants from Boehringer Ingelheim and Merck, and consulting fees from Roche, Sanofi Aventis, AstraZeneca, and The Medicines Company. JM is an employee of AstraZeneca. ND has received consulting or speaking fees from Amgen, AstraZeneca, Bayer, Bristol-Myers Squibb, Boehringer Ingelheim, GlaxoSmithKline, Intercept, MSD, Novartis, Novo-Nordisk, Pfizer, Sanofi, and Servier. SP has received research grant support from AstraZeneca. HB has received research funding from the Instituto de Salud Carlos III (PIE16\/00021), AstraZeneca, BMS, Janssen, and Novartis; consulting fees from Abbott, AstraZeneca, Bayer, BMS-Pfizer, and Novartis; and speaking fees or support for attending scientific meetings from AstraZeneca, Bayer, BMS-Pfizer, Ferrer, Novartis, Servier, and MEDSCAPE-the .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}